Daniel Karp's Insider Trades & SAST Disclosures
Daniel Karp's most recent trade in Organon & Co. was a trade of 3,500 Common Stock done at an average price of $8.2 . Disclosure was reported to the exchange on May 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel Karp.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Purchase of securities on an exchange or from another person at price $ 8.24 per share. | 06 May 2025 | 3,500 | 46,669 | - | 8.2 | 28,828 | Common Stock |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 99,009 | 99,009 | - | - | Stock Option (right to buy) | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 20,147 | 20,147 | - | - | Restricted Stock Units | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 14,184 | 28,369 | - | - | Restricted Stock Units | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 14,184 | 33,546 | - | 0 | Common Stock | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 11,338 | 11,338 | - | - | Restricted Stock Units | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 11,338 | 40,438 | - | 0 | Common Stock | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,861 | 0 | - | - | Restricted Stock Units | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,861 | 41,745 | - | 0 | Common Stock | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 4,446 | 29,100 | - | 14.5 | 64,511 | Common Stock |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,294 | 44,515 | - | 0 | Common Stock | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,294 | 0 | - | - | Restricted Stock Units | |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 3,554 | 36,884 | - | 14.5 | 51,569 | Common Stock |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 1,524 | 40,221 | - | 14.5 | 22,113 | Common Stock |
| Organon & Co. | Daniel Karp | Executive VP, Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2025 | 1,346 | 43,169 | - | 14.5 | 19,530 | Common Stock |
| AlTi Global Inc - Ordinary... | Daniel Karp | Director | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 20 Jan 2023 | 12,500 | 12,500 | - | 9.5 | 118,750 | Class A Common Stock |
| Spectrum Brands Holdings Inc. | Daniel L. Karpel | VP, Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 1,220 | 2,853 (0%) | 0% | 0 | Common Stock | |
| Spectrum Brands Holdings Inc. | Daniel L. Karpel | VP, Corporate Controller & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.97 per share. | 06 Dec 2021 | 287 | 1,633 (0%) | 0% | 100.0 | 28,691 | Common Stock |
| Spectrum Brands Holdings Inc. | Daniel L. Karpel | VP, Corporate Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 1,920 | 1,920 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges